Interferon
Vargas Vorackova, F.; Mata Mendoza, J.M.
Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 33(4): 419-425
1981
ISSN/ISBN: 0034-8376 PMID: 6173909 Document Number: 181378
Document emailed within 1 workday
Related Documents
Balan, V.; Nelson, D.R.; Sulkowski, M.S.; Everson, G.T.; Lambiase, L.R.; Wiesner, R.H.; Dickson, R.C.; Garcia, A.; Moore, P.A.; Yu, R.; Subramanian, G.M. 2006: Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis C Antiviral Therapy 11(7): 901-908Lvovsky, E.A.; D'Souza, J.; Eng, D.; D'Souza, D.; Lvovsky, B.; Hetland, R.; Craver, W.L.; Sobel, S.H. 1988: Tumor response to interferon inducer and radiation effect of serum interferon levels Journal of Biological Regulators and Homeostatic Agents 2(1): 1-6
Akimoto, M.; Ueki, H.; Nakajima, Y.; Matano, S.; Ewasaki, H.; Abe, R.; Kasai, M. 1984: Prevention of 5-FU induced toxicity in C3 H/HE mice with interferon or with interferon inducers (poly 1: C, OK-432, Lentinan) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(7): 1462-1467
Günther, G.; Otto, B. 1993: Interferon. An overview of the state of basic research with special regard to interferon-gamma Arzneimittel-Forschung 43(2): 182-188
Sumpio, B.E.; Ernstoff, M.S.; Kirkwood, J.M. 1984: Urinary excretion of interferon, albumin, and beta 2-microglobulin during interferon treatment Cancer Research 44(8): 3599-3603
Meager, A.; Parti, S.; Webb, K.; Exley, T. 1986: Development of interferon-specific monoclonal antibody for in vitro interferon assays Developments in Biological Standardization 64: 237-248
Corbillet, V.; Celerier, P.; Lebon, P.; Litoux, P.; Dreno, B. 1995: Development of interferon antibodies during the treatment of skin diseases with low-dose recombinant interferon alpha-2a Annales de Medecine Interne 146(6): 399-403
Rubin, B.Y.; Bartal, A.H.; Anderson, S.L.; Millet, S.K.; Hirshaut, Y.; Feit, C. 1983: The anticellular and protein-inducing activities of human gamma interferon preparations are mediated by the interferon Journal of Immunology 130(3): 1019-1020
Tazulakhova, E.B.; Amitina, N.N.; Ershov, F.I. 1985: Interferon-inducing and antiviral effects of inosiplex in combination with high-molecular interferon inducers Biulleten' Eksperimental'noi Biologii i Meditsiny 100(10): 457-459
Russo, D.; Fanin, R.; Zuffa, E.; Damiani, D.; Gallizia, C.; Michieli, M.; Testoni, N.; Benfenati, D.; Visani, G.; Zaccaria, A. 1990: Sequential treatment of Ph-positive chronic myeloid leukemia with interferon gamma and interferon alpha Haematologica 75(4): 334-339
Gutman, N.R.; Manakhova, L.S. 1981: Ability of influenza virus strains to induce interferon and their sensitivity to the action of exogenous interferon Voprosy Virusologii 2: 168-171
Fleischmann, W.R.; Kleyn, K.M.; Baron, S. 1980: Potentiation of antitumor effect of virus-induced interferon by mouse immune interferon preparations Journal of the National Cancer Institute 65(5): 963-966
Weinberg, J.M.; Wolfe, J.T.; Sood, S.; Saruk, M.; Rook, A.H.; Spiers, E.M. 1997: Cutaneous necrosis associated with recombinant interferon injection. Report of three cases with interferon beta-1b and review of the literature Acta Dermato-Venereologica 77(2): 146-148
Koyama, S.; Narita, M. 1988: In vitro effects of interferon-alpha and interferon-gamma on hematopoietic progenitor cells in bone marrow Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 51(8): 1540-1549
Margolick, J.B.; Ambrus, J.L.; Volkman, D.J.; Fauci, A.S. 1986: Human T4+ lymphocytes produce a phagocytosis-inducing factor (PIF) distinct from interferon-alpha and interferon-gamma Journal of Immunology 136(2): 546-554
Gröhn, P. 1989: Treatment of soft tissue sarcomas with interferon with special reference to general features of interferon therapy Acta Chirurgica Scandinavica. Supplementum 549: 50-51
Mels, G.C.; Roffi, L.; Antonelli, G.; Bellati, G.; Pacchetti, S.; Di Nolfo, M.A.; Panizzuti, F.; Moretti, G.; Piperno, A.; Pozzi, M. 1993: Lymphoblastoid interferon in patients with chronic nAnB hepatitis showing relapse during recombinant alpha interferon therapy Progress in Clinical and Biological Research 382: 359-364
Sayers, T.J.; Wiltrout, T.A.; McCormick, K.; Husted, C.; Wiltrout, R.H. 1990: Antitumor effects of alpha-interferon and gamma-interferon on a murine renal cancer (Renca) in vitro and in vivo Cancer Research 50(17): 5414-5420
Orlova, T.G.; Zhdanova, L.V.; Mentkevich, L.M.; Shcheglovitova, O.N.; Solov'ev, V.D. 1979: Interferon-producing activity of bone marrow cells treated with mRNA for interferon when transplanted to irradiated mice Voprosy Virusologii 5: 541-544
Ali, S.; Nazir, G.; Khan, S.A.; Iram, S.; Fatima, F. 2010: Comparative therapeutic response to pegylated interferon plus ribavirin versus interferon alpha-2b in chronic hepatitis C patients Journal of Ayub Medical College Abbottabad: Jamc 22(4): 127-130